Advertisements

TESARO Inc. (TSRO) Stock Quote

Detailed Quote for TESARO Inc. (TSRO)
$ 145.80   -0.81 (-0.55%) Volume: 38.39k 9:44 AM EDT Apr 28, 2017
Today 5d 1m 3m 1y more
Last Price
145.80
Change $
0.81
Change %
0.55%
Tick
N/A
Bid
145.57
Bid Size
100
Ask
146.03
Ask Size
100
Open
147.60
High
147.83
Low
144.84
Prev Close
146.61
Last Trade
9:44
Volume
38.39k
52 Wk Hi
192.940002
52 Wk Low
36.6800003
Market Cap
7.84b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
53,801,752
EPS (TTM)
-8.15999984
PE Ratio
N/A
Exchange
NGS
News and Media for TESARO Inc. (TSRO)
Sector News | Topic News
News for TESARO Inc. (TSRO)
Thu, Apr 27, 2017
8:15 AM TESARO Initiates Registrational Development Program for Anti-PD-1 Antibody TSR-042 - GlobeNewswire
8:03 AM Risk Arbitrage Today: Can Biotech M&A Pick Up Under President Trump? - SeekingAlpha
6:00 AM 3 Things In Biotech You Should Learn Today: April 27, 2017 - SeekingAlpha
Wed, Apr 26, 2017
8:30 AM TESARO Announces Approval of VARUBY\u00AE (Oral Rolapitant Tablets) by European Commission - GlobeNewswire
8:30 AM TESARO Announces Approval of VARUBY\u00AE (Oral Rolapitant Tablets) by European Commission - Thomson Reuters ONE
Tue, Apr 25, 2017
4:15 PM TESARO to Announce First-Quarter 2017 Financial Results on May 9, 2017 - GlobeNewswire
4:15 PM Tesaro Announces Participation in Two Investor Conferences - GlobeNewswire
Fri, Apr 21, 2017
3:32 PM Snippet Roundup: Tesaro's Parp Pricing Stumble And Asco Sneak Peek - SeekingAlpha
9:20 AM Abbvie's Parp Runs Out Of Puff - SeekingAlpha
Thu, Apr 20, 2017
12:43 PM Midday Gainers / Losers - SeekingAlpha
11:55 AM TESARO trips on Zejula pricing scheme; shares down 11% - SeekingAlpha
9:52 AM AbbVie's veliparib flop no big deal - analysts - SeekingAlpha
Wed, Apr 19, 2017
4:15 PM TESARO Announces Availability of Zejula(TM) (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S. - GlobeNewswire
Fri, Apr 07, 2017
8:30 AM Tesaro Wins Awards for Clinical Development Team of the Year and Clinical Partnership of the Year - GlobeNewswire
Mon, Mar 27, 2017
3:47 PM TESARO Announces U.S. FDA Approval Of ZEJULA(TM) (Niraparib) For Women With Recurrent Ovarian Cancer - PR Newswire
3:45 PM TESARO Announces Expanded Development Program for Niraparib Focused on the Treatment of Front-Line Metastatic Ovarian and Lung Cancers and Metastatic Breast Cancer - GlobeNewswire
Fri, Mar 24, 2017
7:59 AM Premarket analyst action - healthcare - SeekingAlpha
Sun, Mar 19, 2017
1:21 AM Week 12 Breakout Forecast: Short-Term Picks To Give You An Edge - SeekingAlpha
Wed, Mar 15, 2017
10:39 AM Lynparza Matches Tesaro's Superstar Status - SeekingAlpha
9:35 AM Biotech Forum Daily Digest: Opko Health Gets A Big 'Shout Out', Spotlight On Adaptimmune - SeekingAlpha
More News for TSRO >>

Tags for TESARO Inc.

Research stocks or mutual funds related to TESARO Inc. by keywords or tags. Find companies that have a similar focus to TSRO. The keywords below have been associated to TSRO by either user submission or electronic means.